 BOSTON--BUSINESS WIRE--AVEO Oncology Nasdaq: AVEO today announced that it has priced its previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to the public of 8.00 per share. The gross proceeds to AVEO from the offering are expected to be 48.0 million before deducting underwriting discounts and commissions and offering expenses. All of the shares in the offering are being sold by AVEO. AVEO has also granted the underwriters a 30-day option t 